Synapse - Breast Medicine Service

Results (4181)

The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces differentiation of human breast cancer cells

Meeting Abstract

Munster, P. N.; Rosen, N.; Rifkind, R.; Marks, P.; Richon, V.
Clinical Cancer Research (2001)

Fulltext@MSK | Save

Phase I trial of 17AAG (17-allylamino) 17-demethoxygeldanamycin (17AAG) in patients (Pts) with advanced cancer

Meeting Abstract

Scher, H. I.; Solit, D. B.; Munster, P. N.; Tong, W. P.; Lawrence, S.; Kenneson, K.; Larson, S.; De La Cruz, A.; Reuter, V.; Rosen, N.
Clinical Cancer Research (2001)

Fulltext@MSK | Save

Effect of cardiac dysfunction on treatment outcome in the Herceptin (trastuzumab) pivotal trial

Meeting Abstract

Tripathy, D.; Seidman, A.; Hudis, C.; Pierri, M. K.; Keefe, D.
Breast Cancer Research and Treatment (2001)

Fulltext@MSK | Save

Role of epoetin alpha in maintaining hemoglobin and quality of life in breast cancer patients receiving adjuvant chemotherapy or chemoradiation

Meeting Abstract

Hudis, C. A.; Williams, D.; Gralow, J. R.
Breast Cancer Research and Treatment (2001)

Fulltext@MSK | Save

[Commentary on] Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk

Journal Article

Robson, M.
Women's Oncology Review (2001)

Fulltext@MSK | Save

[Commentary on] Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial